TMCnet News

Research and Markets: Concise Analysis on the International Enteric Disease Testing Market - Forecasts to 2019
[February 05, 2014]

Research and Markets: Concise Analysis on the International Enteric Disease Testing Market - Forecasts to 2019


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/7lqbq8/enteric_disease) has announced the addition of the "Concise Analysis on the International Enteric Disease Testing Market - Forecasts to 2019" report to their offering.

Various microbes responsible for enteric infections include salmonella, shigella, rotavirus, norovirus, c. difficile, cryptosporidium, vibrio and campylobacter. These diseases may range from asymptomatic to having mild to severe symptoms such as bloody diarrhea, abdominal cramps, stool containing blood or pus, fever and weight loss. Incubation period varies from few days to few weeks depending on the disease and severity. In order to reduce the chance of developing complications, these diseases needed to be diagnosed early.

Earlier, diagnosis of enteric diseases relied on culture results of stool pecimen that involved identification of causative pathogens in a culture medium. However, the trend is now shifting from culture methods to other diagnostic methods owing to limitations associated with culture tests. Major drawbacks associated with culture tests include high cost, labor intensive, requires sophisticated laboratory and a skilled person to perform the diagnosis. On the other hand, enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR (News - Alert)) has made enteric infection diagnosis easy and fast.



In developed regions such as North America and Europe, PCR based diagnosis is most recommended testing method for enteric diseases as it offers high sensitivity and specificity and is considered as easy, accurate, rapid and reliable method of diagnosis. Latest introductions in MALDI-TOF have also been developed for rapid diagnosis of whole organisms without destruction of infection sample. Asia-Pacific accounting for more than 50% of the total global population represents the most profitable market for enteric disease testing in terms of growth and potential.

Key Topics Covered:


1 Preface

2 Executive Summary

3 Enteric Disease Testing Market Overview

4 Global Enteric Disease Testing Market

5 Global Enteric Disease Testing Market, By Geography, 2011 - 2019

6 Key Player Analysis for Enteric Disease Testing Market, 2012

7 Company Profiles

Companies Mentioned:

  • Alere
  • Becton Dickinson & Company
  • Biomerica
  • Biomerieux
  • Bio-Rad
  • Cepheid
  • Coris Bioconcept
  • Diasorin
  • Meridian Bioscience
  • Quest Diagnostics
  • Trinity Biotech

For more information visit http://www.researchandmarkets.com/research/7lqbq8/enteric_disease


[ Back To TMCnet.com's Homepage ]